Trade names or approved names. Part IV. The solution. How should we prescribe?
作者信息
Vere D W
出版信息
Postgrad Med J. 1974 Feb;50(580):122-4. doi: 10.1136/pgmj.50.580.122.
Abstract
Approved names, though often bulky, are preferable on balance to brand names because they identify drugs precisely by compound, often revealing derivation and class of action as well. Brand names at present have the advantage of identifying a preparation. This affirms bio-availability, if that is known, and safeguards the consumer's legal position. But both advantages are against drug defects. It should therefore be hoped that they will become obsolete through pharmaceutical progress, and so do not constitute a lasting reason to confound prescribing accuracy with financial expediency.
摘要
相似文献
1
Trade names or approved names. Part IV. The solution. How should we prescribe?
Postgrad Med J. 1974 Feb;50(580):122-4. doi: 10.1136/pgmj.50.580.122.
2
Trade names or approved names. Part 1. The situation. How doctors prescribe and why.
Postgrad Med J. 1974 Feb;50(580):65-7. doi: 10.1136/pgmj.50.580.65.
3
Trade names or approved names. Part IV. The solution. Introduction.
Postgrad Med J. 1974 Feb;50(580):121. doi: 10.1136/pgmj.50.580.121.
4
Trade names or approved names. Part II. Points of view. The department of health.
Postgrad Med J. 1974 Feb;50(580):77-80. doi: 10.1136/pgmj.50.580.77.
5
Trade names or approved names. Part II. Points of view. The retail pharmacist.
Postgrad Med J. 1974 Feb;50(580):81-2. doi: 10.1136/pgmj.50.580.81.
6
Trade names or approved names. Part 1. The situation Substitution: right or wrong?商品名或批准名。第1部分。情况 替换：对还是错？
Postgrad Med J. 1974 Feb;50(580):68-70. doi: 10.1136/pgmj.50.580.68.
7
Trade names or approved names. Part 11. Points of view. The general practitioner.商品名或批准名。第11部分。观点。全科医生。
Postgrad Med J. 1974 Feb;50(580):88-90. doi: 10.1136/pgmj.50.580.88.
8
Trade names or approved names. Part III. Special cases. Combination products.商品名或批准名。第三部分。特殊情况。组合产品。
Postgrad Med J. 1974 Feb;50(580):103-6. doi: 10.1136/pgmj.50.580.103.
9
Trade names or approved names. Part II. Points of view. The pharmaceutical company.商品名或批准名。第二部分。观点。制药公司。
Postgrad Med J. 1974 Feb;50(580):85-7. doi: 10.1136/pgmj.50.580.85.
10
Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.商品名或批准名。第四部分。解决方案。处方开具与制剂监管。
Postgrad Med J. 1974 Feb;50(580):125-9. doi: 10.1136/pgmj.50.580.125.
Zotero 插件